Tarveda Therapeutics' Series D Round

Tarveda Therapeutics raised a round of funding on February 02, 2017.

Tarveda Therapeutics, fka Blend Therapeutics, is a biopharmaceutical company discovering and developing Pentarins as a new class of targeted anti-cancer medicines to advance the treatment of patients …

Articles about Tarveda Therapeutics' Series D Round: